Director, US PADCEV Consumer & AHP Marketing Secondment (8 months)

Pfizer

Not Interested
Bookmark
Report This Job

profile Job Location:

New York City, NY - USA

profile Monthly Salary: Not Disclosed
Posted on: 30+ days ago
Vacancies: 1 Vacancy

Job Summary

ROLE SUMMARY

PADCEV () is an agent for the treatment of metastatic urothelial cancer. The product was initially launched in 2019 and received full approval for front-line treatment of la/mUC in December 2023. PADCEV in combination with pembrolizumab has demonstrated significant efficacy relative to platinum-based therapy and is now recognized as the next standard of care in front-line la/mUC. PADCEV is a high priority brand within the Pfizer Oncology portfolio and is a key growth driver for the organization. With an indication expansion into muscle-invasive bladder cancer (MIBC) expected during this Secondment it is a very exciting time to join the brand.

What You Will Achieve

This secondment is to provide an excellent opportunity for a high potential colleague on a key Oncology brand while the Consumer/AHP Marketing Director is on maternity leave. The timing is designed to overlap for the first and last month of leave to ensure smooth transitions. This role is responsible for the creation execution and deployment of all strategies related to consumer and AHP (allied health professionals for example nurses NP/PAs and pharmacists) audiences. As PADCEV is co-commercialized with Astellas in the United States the role will work closely with their counterparts at Astellas to ensure joint alignment on strategy budget and execution plans.

Due to the alliance and colleagues around the country candidates must be flexible with working hours to accommodate ET CT and PT time zones. Strong communication actively contributing to a positive team culture working through ambiguity

ROLE RESPONSIBILITIES

  • Lead Patient & AHP strategy and related promotional planning and execution for the PADCEV brand including preparation for the new indication launch in muscle-invasive bladder cancer (MIBC) and continued drive of performance in the front line locally advanced/metastatic urothelial carcinoma (la/mUC).

  • Lead omnichannel Consumer engagement strategy and execution to drive product awareness and activation including social media digital and personal promotion.

  • Partner with Advocacy to develop and deploy bladder cancer awareness initiatives; lead Patient Ambassador initiatives.

  • Lead Media agency to define the AHP strategy and tactical execution for Search and Display; in addition identifying opportunities for field force tactics to improve patient education experience and address AE management questions or concerns.

  • Accountable for Consumer & AHP agency budget to ensure projects are completed on time and within scope in conjunction with Alliance partner(s).

  • Collaborate closely with marketing team colleagues and cross functional team members including Global Marketing Patient Advocacy Team Corporate Comms MLR Market Research Analytics

  • Collaborate closely with all Astellas counterpart to ensure alignment on strategy budget and execution plans

Qualifications

Must-Have

  • BA/BS degree required

  • 8-10 years of pharmaceutical industry experience including 5 years of US marketing or marketing-adjacent experience required

  • Oncology experience strongly preferred

  • Agency or vendor management experience including budget management required

  • Prior experience in consumer marketing preferred

  • Track record of innovation leadership and significant contribution to the growth of brands

  • Demonstrated ability to understand customer needs extract key insights and translate these into meaningful strategies and in market results

  • Strong business acumen including demonstrated strategic marketing and analytical thinking skills

  • Demonstrated ability to manage and deliver results on multiple complex competing projects in a deadline-oriented environment

  • Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers develop and coach others oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact

  • Agile mindset:Track record of pushing boundaries and not accepting status quofinding ways to deliver in the face of accelerated deadlines

  • Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers develop and coach others oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

  • Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers develop and coach others oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

PHYSICAL/MENTAL REQUIREMENTS

  • Physical ability to travel conduct in-office tasks such as computer work and hosting calls.

NON-STANDARD WORK SCHEDULE TRAVEL OR ENVIRONMENT REQUIREMENTS

  • 20% travel will be required - including relevant meetings with Alliance partners POA meetings Advocacy meetings Congresses (if needed)


Other Job Details

  • Last Date to Apply for Job: Nov 4 2025

  • Eligible for Relocation Package: No

  • Secondment 8 months

  • If you are currently in a driving position with a fleet vehicle and this secondment does not require driving as an essential function of the position for 12 months or longer you will be required to turn in your fleet vehicle for the duration of the non-driving secondment. Please refer to the Fleet Policy and Procedures document for more information.

  • Work Location Assignment: Must be able to work from the assigned Pfizer office 2-3 days per week or as needed by the business.

Relocation assistance may be available based on business needs and/or eligibility.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name address and the type of payments or other value received generally for public disclosure. Subject to further legal review and statutory or regulatory clarification which Pfizer intends to pursue reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse your name address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race color religion sex sexual orientation age gender identity or gender expression national origin disability or veteran status. Pfizer also complies with all applicable national state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.

Pfizer endeavors to make to all users. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process and/or interviewing please email. This is to be used solely for accommodation requests with respect to the accessibility of our website online application process and/or interviewing. Requests for any other reason will not be returned.

Marketing and Market Research


Required Experience:

Director

ROLE SUMMARYPADCEV () is an agent for the treatment of metastatic urothelial cancer. The product was initially launched in 2019 and received full approval for front-line treatment of la/mUC in December 2023. PADCEV in combination with pembrolizumab has demonstrated significant efficacy relative to p...
View more view more

Key Skills

  • Digital Marketing
  • B2B Sales
  • Marketing
  • Pardot
  • Marketing Automation
  • Customer Segmentation
  • HubSpot
  • Multichannel Marketing
  • Market Research
  • Affiliate Marketing
  • Social Media Management
  • Lead Generation

About Company

Company Logo

Erfahren Sie mehr über uns als forschendes und produzierendes Pharmaunternehmen: Von unserem Beitrag zum medizinischen Fortschritt bis zur nachhaltigen Produktion.

View Profile View Profile